Health Care & Life Sciences » Biotechnology | Theravance Biopharma Inc.

Theravance Biopharma Inc.

Theravance Biopharma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.86 M
Public Float
17.53 M
Theravance Biopharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.1
Market Cap
$966.68 M
Shares Outstanding
56.14 M
Public Float
41.96 M

Profile

Address
Ugland House
George Town GT KY1
Cayman Islands
Employees -
Website http://www.theravance.com
Updated 07/08/2019
Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Financials

View All
Created with Highcharts 5.0.14Theravance Biopharma Inc.Net Income. Fiscal year is January-December. All values USD Thousands.156 284156 284237 038237 038182 219182 219190 669190 669285 405285 405215 524215 524201320142015201620172018050k100k150k200k250k300k
Created with Highcharts 5.0.14Theravance Biopharma Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.22622611 68811 68842 12642 12648 64848 64815 38615 38660 37060 370201320142015201620172018020k40k60k80k

Rick E. Winningham
Chairman & Chief Executive Officer
Eran Broshy
Independent Director